The average American family spends over $10,000 a year at the grocery store, but that food is seemingly becoming less and less safe to eat. NewsNation's Anna Kooiman reports.
The FDA is currently investigating nine food-borne illnesses. The latest recalls include berries, sprouts and mangoes. This comes as the average American family is spending over $10,000 at the grocery store. Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica NewsNation is your source for fact-based, unbiased news for all Americans.
In its original complaint, Louisiana argued the Biden administration expanded access to mifepristone without properly considering potential safety risks. The state also argued the policy violated the Comstock Act, which generally prohibits sending abortion drugs by mail.
Rachel Maddow: "While it is increasingly clear that we need more resources to track and contain cyclospora and other dangerous foodborne illnesses, we are seeing the opposite unfold in Trump's second term."
Plenty of Americans feel like they're forking over a fortune for groceries —only to get hit with a recall notice that forces them to throw that expensive food out. Why it matters: While grocery prices are driven by complex trade and energy costs, the safety net meant to keep them safe to eat is fraying, creating a dual crisis of affordability and safety. - The average American household pays more than $10,000 on groceries every year, and two-thirds of Americans think they're spending too much. - Prices have increased by more than 18% since 2022, although some foods have seen sharper or smaller increases. What they're saying: "It can be really, really scary out there," Lauren Borsheim, a food policy analyst at Food & Water Watch,…
A three-judge panel on the 5th U.S. Circuit Court of Appeals in New Orleans is poised to hear oral arguments next week in a case that could eventually restrict the nationwide distribution of the abortion drug mifepristone.
Moderna co-founder and board chairman Noubar Afeyan discusses the phase three success of the Moderna-Merck cancer vaccine trial and explains how the vaccine targets unique mutations to help prevent melanoma recurrence on ‘The Claman Countdown.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #moderna #merck #cancer #vaccine #health #medicine #medical #melanoma #science #research #trial #biotech #technology #treatment #breakthrough #healthcare #innovation